Does LEDIPASVIR\SOFOSBUVIR Cause Product packaging quantity issue? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Product packaging quantity issue have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.1% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.
20
Reports of Product packaging quantity issue with LEDIPASVIR\SOFOSBUVIR
0.1%
of all LEDIPASVIR\SOFOSBUVIR reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From LEDIPASVIR\SOFOSBUVIR?
Of the 20 reports, 1 (5.0%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?
Fatigue (4,609)
Headache (4,203)
Nausea (1,471)
Drug ineffective (1,397)
Hepatitis c (1,076)
Diarrhoea (1,065)
Insomnia (1,021)
Hepatocellular carcinoma (640)
Vomiting (623)
Dizziness (604)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Product packaging quantity issue Risk?
LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE
LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT
LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR
LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE
LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB